The impact of parenteral nutrition preparation on bloodstream infection risk and costs


    loading  Checking for direct PDF access through Ovid

Abstract

BACKGROUND:Catheter-related bloodstream infections (BSIs) are a serious problem leading to increased morbidity, longer hospital stay, and hence, additional costs. This study evaluated the risk of BSI and the cost of parenteral nutrition (PN) in Germany.SUBJECTS/METHODS:A retrospective observational chart review of patients hospitalized from October 2009 to April 2011 and receiving PN via ready-to-use three-chamber bag (MCB), single bottle (SB) or hospital compounded admixture (CPN) was conducted across Germany. Propensity score-adjusted models were used to evaluate the association between the type of PN, BSI (Cox Proportional Hazards) and hospitalization cost (generalized linear models) within a subgroup receiving all three macronutrients (lipids, amino acids, glucose).RESULTS:Of the 1995 patient records reviewed (MCB = 816;CPN = 584;SB = 595), 1457 patients received all three macronutrients. After adjustment, SB was associated with an increased hazard of BSI, vs MCB without additions (hazard ratio (HR) (95% confidence interval (CI)) = 2.53 (1.66–3.86)) in the total cohort. Adding supplements to MCB on the ward also increased the BSI risk in both total and subgroup analyses. In patients receiving all three macronutrients, adjusted total costs were MCB (no additions): €6,572 (95% CI: €6,896–6263); CPN: €6,869 (€7,283–6479); SB: €6,872 (€7,242–6521); MCB (ward additions): €7,402 (€7,878–6955); P<0.001; P<0.001.CONCLUSION:Use of MCB does not appear to increase treatment costs, possibly by reducing the risk of infection. This study identified several PN preparation methods associated with a significantly increased hazard for BSI;definitive CPN findings are limited by our inability to distinguish automated from manual pharmacy compounding.

    loading  Loading Related Articles